Schering – Plough – Berlex – Bayer AG
Mirena IUD – Bayer AG & Subsidiaries
Corporate History – Lawsuits – Plaintiff Emails
Date: 02/23/2014
To: Bayer AG – Executive Members & Subsidiaries
RE: Mirena – Bayer AG, Bayer Healthcare, Schering AG, Berlex Corporation, I.G. Farben
Schering Plough – Founded in 1851, by Ernest Christian Friedrich Schering
Company Formed: Schering AG – Germany
History: Following the entry of the United States into World War II in 1941. U.S. President
Franklin D. Roosevelt ordered Schering AG’s, U.S. Assets to be seized. The company was placed under Government administratorship until, 1952, by which all prior assets were sold to corporates his business and generated $254.5 million in sales by 1954. That figure doubled by 1962.
In 1971 Plough merged Plough Chemical Company Incorporated with Schering Corporation. The Schering corporation was a manufacturer of prescription pharmaceuticals, the merger name of the two corporations was named, Schering-Plough. Schering was able to gain entry back into the United State’s by merging with Plough in the pharmaceutical industry.
Release date from U.S. – 1941 to Re-entry date back into U.S. – 1971
Mr. Abe Plough, exhausted his full business ownership in his company and became chairman of the new merging corporation. Five years after the merger in 1976, Plough retired from his company he’d started in 1908.
Schering – Plough remained in America, growing there corporation no back in the United States. By 2005 Schering-Plough had 1.4% market share in the United States., becoming 17th in the top 20 pharmaceutical corporations by sales compiled y IMS Health of America.
Schering-Plough was a full member of the “European Federation of Pharmaceutical Industry and Associations” (EFPIA).
In November 2009, Schering-Plough merged with Merck & Company, or Merck KGAA in a reverse merger. Merck became a subsidiary of Schering-Plough. The two companies manufactured several pharmaceutical drugs, Claritin, and Clarinex, an anti-cholesterol drug Vytorin and a brain tumor drug Temodar.
Clarinex, Claritin, Vytorin, Temodar, Pipeline pharmaceutical Products
Lawsuits
Class-Action Lawsuit Filed Against Claritin’s Maker – 2003
Consumer groups have filed a class-action lawsuit against pharmaceutical giant Schering-Plough – http://product-liability.laws.com/claritin-lawsuit – The [agency] has reviewed these ads and concluded that they are misleading and violate the Federal Food, Drug and Cosmetic Act and applicable regulations and should be discontinued immediately,” says the letter from Joan Hankin, JD, a consumer promotion analyst at the FDA.
The complaint, brought to a New Jersey state court, accuses the drug company of “deceptive advertising and overpricing” for Claritin, America’s most widely prescribed allergy drug.
Schering-Plough Settles Clarinex Class Action for $165 Million –
http://www.bigclassaction.com/settlement/schering-plough-settles-clarinex-
class-action.php– 2010 Specifically, the suit alleged that between May 2000 and February 2001 Schering-Plough made false statements that did not adequately disclose “serious and widespread deficiencies” in its quality and manufacturing operations. This, in turn, risked delay of FDA approval of Clarinex, a successor drug to Claritin.
Vytorin Class Action Lawsuits Mount as Justice Department Investigates – See more at: http://www.aboutlawsuits.com/vytorin-class-action-lawsuits-mount-1636/#sthash.nl7O9PnQ.dpuf – 2008 Vytorin lawsuits have been filed against Merck and Schering-Plough involving consumer fraud actions for selling a medication which provides no benefits, cases alleging personal injuries caused by the drug and claims to establish medical monitoring for users who were given
the drug.
Temodar Bone Marrow Injury & Birth Defects –
http://www.rotlaw.com/temodar/
Two Temodar lawsuits were filed against the drug’s parent companies, regarding illicit marketing and sales practices. In 2006, Schering-Plough, the former Temodar manufacturer, faced a Department of Justice investigation which uncovered mis-marketing and illegal sales practices.
The Temodar lawsuit found that the company marketed Temodar for unapproved forms of brain cancer, bribed doctors and promoted the sale of its Temodar products. For these charges, the company was ultimately forced to pay $435 million fines. – See more at: http://product-liability.laws.com/temodar
Following the resolution of this Temodar lawsuit, the drug was purchased by Merck. In 2011, the Department of Justice issued a subpoena seeking materials concerning marketing of Temodar dosage products.
This Temodar lawsuit was issued as part of an investigation which could lead to a Temodar concerning marketing abuses committed by Schering-Plough. In the past, similar Temodar lawsuits have included a fund for victims of adverse effects as a condition of settlement. http://product-liability.laws.com/temodar-lawsuit
Summary: Schering-Plough 1971 – Merck & Company or Merck KGAA merger – 2009
Merck & Company – Schering Plough Schering Products: sugammadex, Cerazette, Desloratadines, Neoclarit, Esmeron, Famvir, Famcilovir, Intron A & PEG-Intron, Levitra, Livial, Marvelon, NuvaRing, Quazepam, Remeron, Buprenorphine, Zetia; OTC: Afrin, Coricidin, Coppertone, Dr. Scholl’s, Zinka, Bain de Soleil, PD-1 antibody.
Schering-Plough – Merck & Company
Organon Research Analysis
2004 – Schering – Plough was accused of marketing gimmicks and payoffs to doctors for prescribing the company’s pharmaceutical products. At that time Schering entered into a consent decree with the FDA in 3/2002, from their manufacturing problems with Albuterol inhaler. Schering-Plough was ordered to pay $500 Million US dollars to the US Treasury.
Bridon (sugammadex’s) – Rejected 3x by U.S. FDA – 2008 due to hypersensitivity reaction concerns to the drug. Clinical trial
inconsistencies
Approved by the European Union – 2008
Sugammadex’s – PD-1 antibody, repoductive medicine, contraception, psychiatry, HRT, anesthesia, Diosynth, birth control pills,
Marvelon, asenapine: some products acquired by purchase of Organon of Scotland
Organon Company Analysis:
Orgination: Akzo Nobel: 1646 – Sweden-Denmark-1777-
Organon: Human health business unit of Akzo Nobel – 80yrs.(Pharmaceutical industry)
Founded: Dr. Saal van Zwanenberg in Oss, Netherlands – 1923
Zwanenberg-Organon – New House Research – Scotland, United Kingdom, Courtaulds
Products – estrogens, insulin, cortisone, fibre
Koninklijke Zawnenberg Organon (KZO) – Fiber company AKZO
Base: New Jersery – Arnhem, Amsterdam
Manufacturing: Netherlands, Germany, United Kingdom, Ireland, China, Japan, Americas. High-Tech coatings, artificial fibers, paint,
chemicals, vetinary,
2007 Schering-Plough New Jersey, acquired Organon, 2009 Schering-Plough mergered with Merck and Company aka Merck Sharp &
Dohme or MSD
Schering-Plough, N.J. The American Drug Maker agrees to purchase Akzko Nobel’s Organon Biosciences Unit – valued @ 14.4Billion –
13.7x’s EBIT
The merger astounded many investors, who were waiting for the announcement of a planned IPO offering of Organon, the maker of birth control pills, for about $10 billion.
Azko Nobel world’s largest paint maker and coatings, chemicals – Amsterdam
Akzo – Last European company with chemical and pharmaceutical
1895 – Akzo Nobel’s: Eka Chemicals Pulp and paper chemicals
1923 – Produced Insulin from pancreases of animals
1968- Courtaulds acquires international paints
1969 – Merger AKU – KZO = AKZO
1994 – Akzo Nobel industries merge Akzo Nobel
1998 Akzo acquires – Courtaulads
2007 – Akzo Nobel sells Organon Biosciences NV – New Jersey Schering – Plough
Research Analysis
Organon – Akzo Nobel Analysis
CFO: Organon Biosciences N.V. – Arhem, Netherlands – Dr. Jorg Spiekerkotter – 2006
Prior: Schering AG executive board member responsible for Leader of Finance Administration and Human Resources – Also prior, Head of Legal Hoescht Schering Agrevo. Organon hire’s Dr. Spiekerkotter as CFO, U.S. Schering-Plough New Jersey purchases
Organon a year later – 2007
Dr. Spiekerkotter CFO and board member of management leaves Organon Biosciences N.V., 2007. After the Schering-Plough purchase of Organon, Akzo Nobel, reduced pension liabilities, debt and paid for a share buy back of 1.3Million
Organon Pharmaceutical Inconsistencies:
Akzo Nobel Feels the pinned as Organon contraceptive sales drop in 2002
The Organon units of Akzo Nobel NV faired poorer than competitor Schering AG reporting a two perecent a year – on – year decline in the use of the contraceptive pill in the Netherlands in the first half of 2002. Sales of third-generation pills recorded the worst fall, declining 13% over a review period. Sales of Organon’s third-generation pills Marvelon & Mercilon fell 19% and 21%, while Schering’s Femodeen fell 18%.
(AFX Report)
Media – 2001 Alerts:
Users of third-generation pills had 70% greater chance of developing thrombosis than users of second-generation pills.
Dutch Foundation Pharmaceutical Statistics: Market leader Microgynon, Schering’s second generation pills, appears to have benefited from a drop in sales of third-generation pills – research published by the Dutch Foundation (SFK) indicates 13%
increase in the first half of sales. In addition, third-generation pills are were losing ground to Schering’s “Yasmin,” a pill launched in the Netherlands 4/2001. Organon was battling negative news regarding Implanon – a contraceptive inserted under the skin.
Women filed lawsuits, some claims stating they had fell pregnant while using the product, headaches, vein inflammation, bleeding and more lawsuit claims.
http://www.nytimes.com/1999/08/27/us/maker-of-norplant-offers-a-settlement-in-suit-over-effects.html Maker of Norplant Offers a Settlement In Suit Over Effects
(Plaintiff: Also participated in Norplant lawsuit and settlement)
Norplant II developed by Population Council Schering (OY) & Norplant 1 by Wyeth
Schering AG, Akzo Nobel’s Unit to end collaboration on Male Contraceptives – 2006
Schering AG and Akzo Nobel’s Organon unit will terminate a research collaboration into male fertility control at the end of Phase II clinical trial, which was designed to test a combination of two hormones known to suppress sperm production.
Bayer – Berlex
Research Analysis
Schering AG – Dates back to Chemische Fabrik auf Actien – Chemicals operations
1930’s – Company diversified for Schering AG
1876 – Schering Glatz – Medicine distribution company launched – 1929 dissolved
1929 – Established Schering Corporation hormone research and synthesize steroid drugs based in New York
Formed Berlex Corporation in 1979 after acquiring assets of the Internal Medicine division of Cooper Laboratories, New Jersey
Area’s – Cardiovascular disease, birth control, diagnostic imaging, endocrinology
1980’s: Iodinated contrast agents used in imaging launched in U.S.
1982: Oral contraceptives, Leveln and Tri-Leveln, Magnevist launched
Schering- Plough sued Schering AG, claiming Berlex infringed upon it’s trademark
Results: Schering AG agreed to use the Schering name in the U.S., and Canada in connection with its pharmaceutical products, relying on the Berlex trademark.
Triton and Codon U.S. Corporation consolidation and purchase to form Berlex Biosciences of California – prior Ortho Research Center – built by Ortho Division of Chevron Chemical Company – Purchased @ $53million
Schering acquired Shell Oil biotech portion 1990 – Fludura, Betaseron
Schering acquires in 1993 – Chevron Chemical Company
Co-Partnership: Abbott Laboratories to sell Magnevist and Ultravist
Berlex Products: Fludara, Betaseron, Climara, Feridex I.V.,
Berlex acquired by Bayer AG
Berlex Lawsuits – Magnevist, Fludara, Betaseron
http://www.drug-injury.com/drug_injury/magnevist/
FDA Panel Suggests Bayer, GE MRI Drugs Be Restricted
Critical Drug Recall and Drug Shortages http://www.gilmanlawllp.com/defective-drug-side-effect-lawsuits/ben-venue-and-novartis-drug-recalls-and-shortages/
In the case of Ben Venue Laboratories, the shut-down of its Ohio manufacturing plant has resulted in the recall of the Fludara leukemia drug, as well as shortages of vital medications, including the life-saving cancer drugs, methotrexate and Doxil.
Betaseron – BigClassAction.com: Class Action News … http://www.bigclassaction.com/lawsuit/betaseron.php –
Berlex, Inc., the manufacturer of the medication, recently contacted healthcare professionals to remind them about certain aspects of the prescribing information for Betaseron as it relates to liver toxicity.
Bayer AG – Berlex – Schering
Research & Analysis
Berlex
1999 launched – Acutect and Neotect lmaging products
2000 – Berlex Products launched – Levulan Kerstick used to treat keratoses
Betapace AF – replacement for Betapace and generic sotalol
Campath, Refludan, Finevin, Mirena – Iud, Yasmin, Leukine, Finacea
Berlex marketed some 20 products such as oral contraceptives called Yasmin, and Mirena, a implanted contraceptive and medicines to treat multiple sclerosis, dermatology disorders and cancers
Berlex contributed $1.2 billion in annual sales, which was one-quarter of it’s parent corporation Schering AG total revenue’s.
Bayer
Bayer AG- Founded Friedrich Bayer & Johann Freidrich Weskott – 1863
1
st Product – acetylsalicylic acid (Aspirin) discovered by French Chemist Charles Frederic Gernhardt in 1853
1899 Bayer trademark of Aspirin was registered After World War I U.S. confiscation of assets – Lost Trademark status in U.S., UK, France – Trademark name currently registered in 80 countries under Bayer AG
1904 – Established Bayer Cross logo only for doctors and pharmacists Bayer’s U.S., confiscated assets acquired by U.S. Sterling Drug aka Sterling Winthrop Bayer became a subsidiary of IG Farben, German Chemical company conglomerate
World War II
IG Farben known for using slave labor in factories attached to concentration camps
Mauthausen-Gusen, concentration camps with 42.5% ownership
IG Farben produced Zyklon B – Chemical used in gas chamber of Auschwitz
After World War II IG Farben – Bayer separated into individual corporations
IG Farben ordered closed by Soviet Union for war reparations although, known for currently trading on Germany stock exchange
Bayer AG – Berlex – Schering
Research and Analysis
Bayer AG Executive Fritz ter Meer, was sentenced to 7yrs. In prison by the Nuremberg War Crimes Tribunal, when released he was appointed on the supervisory board of Bayer AG in 1956 – On the facts proven on record, the defendants who were members of the [managing board of I.G.] were accessories to and took a consenting part in the commission of war crimes and crimes against humanity as alleged in count three of indictments.
1978 – Bayer purchases – Miles laboratories and subsidiaries, Miles Canada, Cutter Laboratories – Products: Alka Seltzer, Flinstone Vitamins, One-A-Day vitimans, and Cutter insect, repellant
1994 – Bayer purchase Sterling Winthrop’s – OTC portion from SmithKline Beachman aka – Galxo Smith Kline – Enabling Bayer to acquire U.S., Canadian trademark rights to Bayer and Bayer Cross, as well as Aspirin trademark in Canada, that was previously
confiscated.
Bayer AG reorganized into a Holding Company in 2003 – Core businesses were transformed into limited companies, controlled by
Bayer AG
Bayer CropScience AG, Bayer Healthcare, Bayer Material Science, Bayer Chemicals AG, Bayer Business Services GmbH, and Bayer
Industry Services GmbH & Co. OHG,
Bayer shares: Frankfurt Stock Exchange, London Stock Exchange, N.Y. Stock Exchange
Bayers 2004 Chemical reorganization – Formed Lanxess excluding H.S. Starack and Wolff Walsrode – polymers – Lanxess listed on
Frankfort Stock Exchange – 2005
2004 – Bayer Healthcare AG – Acquired OTC Pharmaceutica divison of Roche Pharmaceutical
2006 – Merck Kga $14.6 billion dollar take over Schering AG surpassed Bayer $19.5 bid
2007 – Bayer Healthcare Diagnostic Division acquires Siemens Medical Solutions
2008 – Bayer Healthcare acquires OTC U.S. Company Sagmel, Inc – which distributed
to most of common wealth countries, Russia, Ukraine, Kazakhstan, Belarus etc.,
Currently holding subsidiaries all over the world – Bayer’s holding company located in Germany
Bayer specialty area’s: Bayer Healthcare – Pharmaceutical and medical product sub-group – Bayer Healthcare 4 divisions – Bayer
Consumer Care, Bayer Animal Health, Bayer Medical Care, Bayer Schering Pharma
2007 Bayer Pharma took over Schering AG – Berlex and formed “Bayer Schering Pharma,” the largest take over in Bayer’s history. Named changed to Bayer Pharma in 2011.
Bayer AG – Berlex – Schering
Research and Analysis
Bayer Healthcare Pharmaceuticals is divided into two business units = General Medicine and Specialty Medicine. Women’s healthcare is example of General Medicine business unit.
Bayer’s Pharma unit produces birth control pills Yaz and Yasmin. Both pills use a newer type of progesterone a hormone called
drospirenone in combination of estrogen. (How many times had these products been passed through multiple mergers?)
Yaz was advertised as a treatment for premenstrual dysphroic disorder (PMDD), and moderate acne. Bayer also picked up Nexavar and Betaferon/Betaseron, and blood clotting drug, Kogenate,
(Many of these drugs were passed down by several prior German corporations)
2009 – U.S. Adrea, entered a global agreement with Bayer Healthcare AG, a subsidiary of Bayer AG. Where Bayer was in control of the completion of the ongoing phase I and phase II studies of RDEA119, which Bayer would be responsible for the further development and commercialization of RDEA119 and any of Adrea’s other MEK inhibitors.
*United States Adrea Biosciences, was acquired by AstraZeneca in 2012 a biotechnology company
AstraZeneca – Formed in 1913 in Sodertalje, Sweden by 400 doctors and apothercaries formed Astra AB. In 1993 British chemicals ICI consolidated it’s pharmaceutical business and its agrochemicals, specialty businesses, to form, The Zeneca Group plc.
1999 – Astra and Zeneca Group merged pharmaceutical companies to form AstraZeneca plc – U.S Headquarters in Wilmington,
Delaware
Astra AB – British multinational pharmaceutical company based in U.K.
Products by Bayer AG and multiple subsidiaries: Women reproductive,
Aspirin, analgesic, antipyretic, anticoagulant medicine, Prontosil, Levitra,
Herion (diacetylmorphine) formerly sold as cough treatment, Sulonamide,
Ciprofloxacin, Polyurethane, Polycarbonate, CD’s, Makrolon, Suramin-Parathion, Insecticide Propoxur, Primodos – hormone pregnancy test
BAYER’S SPECIALTY AREA’S
Bayer Specialty Medicine business unit – Diagnostic Imaging
Contrast agents from his unit helps play crucial role in precise early diagnosis – Computed tomography (CT), magnetic resonance
imaging (MRI) and ultrasound
The Pet tracer Florbetaben, in Bayer’s pipeline is to recognize beta Amyloid, on of the pathological hallmarks of Alzheimer’s disease.
Bayer Consumer Care – Manages Bayer’s OTC medicine portfolio – Key products include, Aspirin, Aleve, food supplements, Redoxon, and Berocca, and skin products Bepanthen and Bepanthol.
Bayer Diabetes Care – Manages Bayer’s medical device portfolio, Key products; Mirena Iud, Blood glucose monitors, Contour Next EZ (XT), Contour USB, Breeze 2
Bayer Material Science: High-Tech Polymers, and develops solutions for a broad range of application relevant to everyday life
Bayer Business Services: Technology infrastructure and technical support, portion of Bayer USA and Bayer Canada – Bayer AG USA
Headquarters of North America Service Desk, and the Central IT Help Desk – Located in Robinson Township, Pennsylvania
Bayer Technology Services: Plant engineering, construction, optimization. Currenta; offers services for the chemical industry,
including utility supply, waste management, infrastructure, safety, security, analytic and vocational training
1904: Founded sports club, “Turn-und-Spielverein der Farbenfabriken vorm. Friedr. Bayer & Co., later SV Bayer 04, TSV Bayer 04
Levekusen, 1984 Bayer 04 Leverkusen
2014: Bayer, Novartis, Reckitt eye $10B-$12B bids for Merck consumer unit
Bayer AG -Berlex aka Schering
Lawsuit Research & Analysis
A cite from http://www.haemophilia-litigation.com/, access date 31 May 2006:
“After 1978, there were four major companies in the United States engaged in the manufacture, production and sale of Factor VIII and IX: Armour Pharmaceutical Company, Bayer Corporation and its Cutter Biological division, Baxter Healthcare and its Hyland
Pharmaceutical division and Alpha Therapeutic Corporation, which have been or are defendants in certain lawsuits.
The plaintiffs allege that the companies manufactured and sold blood factor products as beneficial “medicines” that were, in fact of
likely to be contaminated with HIV and/or HCV. This resulted in the mass infection and/or deaths of thousands of haemophiliac
worldwide
Baycor – After 52 deaths were blamed on an alleged side effect of Bayer’s anticholesterol drug Baycol, its manufacture and sale were discontinued in 2001. The side effect was rhabdomyolysis, causingrenal failure, which occurred with a tenfold greater frequency in patients treated with Baycol in comparison to those prescribed alternate medications of the statin class
Medicaid reimbursement
In January 2001, Bayer agreed to pay $14 million to the United States and 45 states to settle allegations under the federal False Claims Act that the company caused physicians and other health care providers to submit fraudulently inflated reimbursement claims to Medicaid Methyl parathion poisoning case – In October 2001, Bayer was taken to court after 24 children in the remote Andean village of Tauccamarca, Peru were killed and 18 severely poisoned when they drank a powdered milk substitute contaminated with the insecticide methyl parathion.
A Peruvian Congressional Subcommittee found significant evidence of criminal responsibility by Bayer and the Peruvian Ministry of Agriculture Liberty Link rice – In August 2006, it became apparent that the United States rice crop had been contaminated with unapproved genetically engineered Bayer CropScience rice. The genetically engineered rice has an herbicide-resistance trait. These forms of rice are commonly referred to among US rice growers as “Liberty Link rice 601” or “LL 601”. Approximately 100 varieties of rice are produced primarily in Arkansas,
Texas,Louisiana, Mississippi, Missouri, and California.
Bayer AG -Berlex aka Schering
Lawsuit Research
2006 Trasylol safety advisory – In September 2006, Bayer was faulted by the FDA for not revealing during testimony the existence of a commissioned retrospective study of 67,000 patients, 30,000 of whom received Trasylol and the rest other antifibrinolytics. The study concluded Trasylol carried greater risks.
The FDA was alerted to the study by one of the researchers involved. Although the FDA issued a statement of concern, they did not change their recommendation that the drug may benefit certain patients. In a Public Health Advisory Update dated 3 October
2006, the FDA recommended “physicians consider limiting Trasylol use to those situations in which the clinical benefit of reduced
blood loss is necessary to medical management and outweighs the potential risks” and carefully monitor patients.The FDA took
Trasylol off the market on 5 November 2007.
Prostate cancer claims – In October 2009, the Center for Science in the Public Interest sued Bayer for “falsely claiming that the selenium in Men’s One-A-Day multivitamins might reduce the risk of prostate cancer
Yasmin / Yaz birth control pills – The FDA has repeatedly warned and punished Bayer for misstating the benefits of Yasmin (also known as Yaz) while understating its risks. In 2011, the FDA’s panel of experts voted 21-5 that the labeling on Yaz was inadequate and needed more information about the potential risk of blood clots in the legs and lungs. The former president of the Australian Medical Associationwas nearly killed by a blood clot that resulted from taking the pill.
The pill has been linked to 23 deaths in Canada. In April 2012, the FDA ordered Bayer to change its U.S. labeling to reference the increased risk for blood clots Neonicotinoid pesticides Clothianidin
In December 2010, a leaked memo from the EPA’s Environmental Fate and Effects Division asserted “Clothianidin’s (Bayer’s neonicotinoid pesticide) major risk concern is to non-target insects (that is, honey bees). Exposure through contaminated pollen and nectar and potential toxic effects therefore remain an uncertainty for pollinators.
“In January 2011,Avaaz.org launched an online petition to ban neonicotinoid pesticides Imidacloprid French and Nova Scotian beekeepers claim Bayer’s seed treatment midacloprid kills honeybees. France has since issued a provisional ban on the use of
imidacloprid for corn seed treatment pending further action. A consortium of U.S. beekeepers filed a civil suit against Bayer CropScience for alleged losses.
Bayer AG -Berlex aka Schering
Lawsuit Research and Analysis
Europe restrictions & challenge The European Commission has restricted the use of both of Bayer’s neonicotinoids. Bayer is challenging the restrictions.
Nexavar claims In an interview given to the Businessweek following controversies surrounding the Indian government’s decision to award a compulsory license to Indian company Natco Pharma Ltd. for Naxavar (Sorafenib), Bayer CEO Marijn Dekkers equated the compulsory license with theft. Regarding targeted markets, he said, “Is this going to have a big effect on our business model? No, because we did not develop this product for the Indian market, let’s be honest. We developed this product for Western patients who can afford this product, quite honestly. It is an expensive product, being an oncology product.”
Chemical Spills:
In 28 August 2008, an explosion occurred at the Bayer CropScience facility at Institute,West Virginia. A runaway reaction ruptured a tank and the resulting explosion killed two employees. The ruptured tank was close to a methyl isocyanate tank which was undamaged by the explosion
Bayer Sued Over Unsupported Prostate Cancer Claims on One A Day 10/2009 http://www.cspinet.org/new/200910011.html
BAYER TO PAY $14 MILLION TO SETTLE CLAIMS FOR CAUSING PROVIDERS TO SUBMIT FRAUDULENT CLAIMS
TO 45 STATE MEDICAID PROGRAMS – January 2001 – http://www.justice.gov/opa/pr/2001/January/039civ.htm
Bayer Sold HIV-Risky Meds – 5/2003 http://www.cbsnews.com/news/bayer-sold-hiv-risky-meds/
BAYER FOUND RESPONSIBLE FOR POISONING OF CHILDREN IN PERU – http://www.twnside.org.sg/title/2410.htm
Bayer AG -Berlex aka Schering
Lawsuit Research & Analysis
FDA to Review Safety Issues Surrounding Leading Birth Control Pill Yaz – 12/2011
http://abcnews.go.com/Health/fda-discuss-safety-issues-surrounding-leading-birth-control/story?id=15099220
Yaz, Yasmin birth control pills linked to 23 deaths in Canada – 7/2013 http://www.nydailynews.com/life-style/health/yaz-yasmin-birth-
control-pills-linked-23-deaths-canada-article-1.1370853#ixzz2uD2nxBf7
Yaz and Yasmin birth control pills linked to 23 deaths: Health Canada documents
http://www.ctvnews.ca/health/health-headlines/yaz-and-yasmin-birth-control-pills-linked-to-23-deaths-health-canada-documents-
1.1321110#ixzz2uD3dzpwU – 06/2013
Neonicotinoids: Syngenta and Bayer go to court against the European Commission
http://www.slowfood.com/sloweurope/eng/news/191739/-neonicotinoids-syngenta-and-bayer-go-to-court-against-the-european-
commission 3/2013
Leaked document shows EPA allowed bee-toxic pesticide despite own scientists’ red flags- http://grist.org/article/food-2010-12-10-leaked-documents-show-epa-allowed-bee-toxic-pesticide/ 12/2010
Bayer in settlement over Cipro pricing – http://www.cbgnetwork.org/5208.html 9/2013
The spying Scotsman who hunted the Nazis of New York: The amazing story of Britain’s clandestine war on Hitler’s agents… and his big- money backers in the US –
http://www.dailymail.co.uk/news/article-2530447/ The-spying-Scotsman-hunted-Nazis-New-York-The-amazing-story-Britains-clandestine-war-Hitlers-agents-big-money-backers 12/2013
Primodos victims from UK demand apology – Cologne, Germany – 26th April 2013 Bayer Shareholder Meeting – Speech Valerie Williams Lipobay/Baycol Victim Goes To Court – Argentina: BAYER Sentenced To Pay Compensation – http://www.cbgnetwork.org/4649.html
10/2013
Bayer AG -Berlex aka Schering
Lawsuit Research Analysis
State ignored plan for tougher chemical oversight – West Virginia ignores a plan for tougher chemical oversight which
was worked out after an explosion in BAYER ́s Institute plant (more info). 300,000 residents are still without usable water
after a chemical spill – 1/2014 http://www.cbgnetwork.org/5405.html
Leaked Documents Reveal the Secret Finances of a Pro-Industry Science Group –
http://www.cbgnetwork.org/5301.html 10/2013
Whistleblower Lawsuit Filed Over Baycol Fraud – http://www.cbgnetwork.org/2703.html 4/2008
Bayer Held Back on Drug Dangers – http://www.cbgnetwork.org/288.html
11/2004
Has died / Hemophiliacs infected by Bayer products – 8/2012 http://www.cbgnetwork.org/4607.html
Bayer, Baxter pay multimillion indemnity to haemophiliacs –
http://www.cbgnetwork.org/3678.html – Settlement in the US with victims from 22 countries / HIV
infections were preventable / “why is BAYER concealing the payments? 1/2010
NY Times: Bayer sold AIDS infected blood product – 5/2003
http://www.cbgnetwork.org/378.html
US elections: BAYER donates to Republicans and Tea Party-????? http://www.cbgnetwork.org/4595.html – 8/2012
Trial-related deaths in India – Open letter to BAYER – Bayer AG
CEO Marijn Dekkers -http://www.cbgnetwork.org/4109.html 10/2011
BAYER: Marketing Expenses Concealed – http://www.cbgnetwork.org/4317.html – 3/2012
Papantonio: Bayer’s Deceptive Marketing Is Killing Women – https://www.youtube.com/watch?v=19zwklFd9z0 3/2013
Bayer AG -Berlex aka Schering
Lawsuit Research & Analysis
$300 Million Compensation in the US
Settlements in Yaz litigation continue, mediator is “cautiously optimistic” that end is in sight – http://www.cbgnetwork.org/4512.html
6/2012
Yaz: Food and Drug Administration to Discuss Dangerous Contraceptive Pills – http://www.cbgnetwork.org/4173.html 11/2011
Bayer contraceptive advert breaches Code of Practice – http://www.cbgnetwork.org/3922.html 5/2011
Newer Birth Control Pills Carry a Higher Risk of Blood Clots – http://www.cbgnetwork.org/3803.html
4/2011 – Complete Study “Risk of venous thromboembolism in users of oral contraceptives containing drospirenone”
(DownloadBMJ_Study_Drospirenone.pdf) and the study on US data
Yaz victims to appear in Bayer shareholder meeting
Ban demanded / Coalition introduces countermotions / more than 50 deaths in the US – http://www.cbgnetwork.org/3327.html
4/2010
RISK OF THROMBOEMBOLISM ASSOCIATED WITH DROSPIRENONE-CONTAINING CONTRACEPTIVES (YASMIN, YAZ, MIRENA – IUD
ETC.) http://www.arznei-telegramm.de/journal/j_0710_a.php3?&knr=073085/318353&name1=ENCEPUR&organ=Sinnesorgane
10/07
Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives. –
http://www.ncbi.nlm.nih.gov/pubmed?
Db=pubmed&Cmd=ShowDetailView&TermToSearch=17766604&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPa
09/2007
Safety of a new oral contraceptive containing drospirenone. – http://www.ncbi.nlm.nih.gov/pubmed?
Db=pubmed&Cmd=ShowDetailView&TermToSearch=15471507&ordinalpos=8&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPa
Bayer AG -Berlex aka Schering
Lawsuit Research and Analysis
Risk of hyperkalemia in women taking ethinylestradiol/drospirenone and other oral contraceptives. –
http://www.ncbi.nlm.nih.gov/pubmed/18929734 8/2008
Schering AG Storms Birth Control Market http://www.forbes.com/2003/07/11/cx_ad_0710shr.html 7/2003
Coalition introduces Countermotion on blood thinner Xarelto – http://www.cbgnetwork.org/4337.html – 4/2012
Bayer Sells AIDS-Infected Drug Banned in U.S. in Europe, Asia –
http://articles.mercola.com/sites/articles/archive/2006/08/05/bayer-sells-aids-infected-drug-banned-in-us-in-europe-asia.aspx
– 8/2006
IG Farben – Bayer AG
IG Farben to be dissolved -The company’s shares continue to trade on the German stock exchange even thought it went into
liquidation in 1952. IG Farben has been heavily criticized for not paying any compensation to former Nazi slave laborers after hundreds of Germany’s leading industrial companies contributed to a 10bn Deutschmark fund this year. Germany’s IG Farben, the company that made the Zyklon-B gas used in the Nazi death camps, has announced it will be dissolved by 2003?
http://news.bbc.co.uk/2/hi/business/1549092.stm
In year 1928, the American holdings of IG Farben, namely, the American branches of Bayer Company, General Aniline Works, Agfa Ansco, and Winthrop Chemical Company, were organized into a Swiss holding company, which was christened Internationale Gesellschaft für Chemische Unternehmungen AG or IG Chemie, in short. The controlling interest of this entity rested with IG Farben in Germany. In the following year, 1929, just a decade before the outbreak of the Second World War, these American firms merged to become American IG Chemical Corporation, or American IG, later renamed General Aniline & Film. –
http://en.wikipedia.org/wiki/American_IG
In 1952, IG Farben was split into BASF, Bayer, an Hoechst again.
German chemical companies —Badische Anilin- und Sodafabrik Ludwigshafen (BASF), Bayer, Agfa, Hoechst,Weiler-ter-Meer, and Griesheim-Elektron. These six companies were merged intoInteressen-Gemeinschaft Farbenindustrie AG or, IG Farben, for short.
Bayer AG -Berlex aka Schering
Lawsuit Research and Analysis
RAG To Take Over Degussa – http://cen.acs.org/articles/84/i1/RAG-Take-Over-Degussa.html 1/2006
Bayer Combination Aspirin Class Action Lawsuit Settlement –
http://www.topclassactions.com/lawsuit-settlements/lawsuit-news/14735-checks-go-bayer-combination-aspirin-class-action-settlement/ -Checks Go Out in
Bayer Combination Aspirin Class Action Settlement
Bayer HealthCare Pharmaceuticals Gender Discrimination Class Action Lawsuit Complaint
Female Bayer HealthCare Pharmaceuticals Employees File Gender Discrimination Class Action Lawsuit Complaint Against Bayer
HealthCare Pharmaceuticals. http://classactionlawsuitsinthenews.com/class-action-lawsuits/bayer-healthcare-pharmaceuticals-gender-discrimination-class-action-lawsuit-complaint/ 3/2011
Bayer’s Yasmin Lawsuit Settlements Rise to $402.6 Million – http://www.businessweek.com/news/2012-07-31/bayer-s-yasmin-lawsuit-settlements-rise-to-402-dot-6-million 7/2013
Bayer Combination Aspirin Multidistrict Litigation – http://www.douglasandlondon.com/legal-news/bayer-combination-aspirin-multidistrict-litigation/Yasmin/Yaz Litigation Heats Up, Bayer Accuses Litigation Lawyers of “Negative Advertising” –
http://www.lawyersandsettlements.com/articles/yasmin-side-effects-yaz-blood/yasmin-birth-control-pill-yaz-side-effects-35-
14476.html#.UwsEMPldVQ4 5/2010
MIRENA IUD and Risk of Uterine Perforation – http://www.lawyersandsettlements.com/lawsuit/mirena-IUD.html#.UwsElvldVQ4 1/2014
Bayer IUD Litigation Consolidated in New York – http://www.nationallawjournal.com/id=1202597081274?
slreturn=20140124033833 4/2013
Bayer Cipro Drug Litigation Settlement – ttp://classactionsnews.com/settlements/bayer-cipro-drug-litigation-settlement 3/2014
Mirena IUD Migration Problems Result in Lawsuit Against Bayer – http://www.aboutlawsuits.com/mirena-iud-migration-problems-lawsuit-31490/#sthash.6SHEPghs.dpuf 8/2012 – Mirena IUD Reported Problems and Complications Topped 70,000 –
http://www.aboutlawsuits.com/mirena-iud-problems-complications-report-49000/#sthash.ps6wrOVy.dpuf
Department of Health and Human Services
Consumer Advocacy Business Industry Research & Investigations (CABIRI) 
You must be logged in to post a comment.